Literature DB >> 9291813

Trends of in situ carcinoma of the breast in Vaud, Switzerland.

F Levi1, V C Te, L Randimbison, C La Vecchia.   

Abstract

Time trends in incidence of in situ carcinoma of the breast over the period of 1977-1994 were analysed by histological type and age group, using data from the Cancer Registry of the Swiss Canton of Vaud, covering a population of approximately 295,000 women in 1990. Overall, 399 women with carcinoma in situ of the breast were registered. Age-adjusted (on the world population) incidence rates increased from 2.1/100,000 women in 1977-1979 to 9.4 in 1992-1994 (4.5-fold increase), and the rise was appreciably greater for ductal carcinoma in situ (DCIS, from 1.0 to 7.1/100,000) than for lobular carcinoma in situ (LCIS, from 1.0 to 2.3/100,000). The largest increase was registered between 1983 and 1992, whereas incidence rates tended to level off over the most recent calendar period. The upward trends were observed in all age groups above 40 years, but chiefly in the age groups 40-49 and 50-69, whose rates were higher than for women over the age of 70 years. These findings suggest that the adoption of mammography in this population during the 1980s is partly or largely responsible for the observed trends. Incidence rates of in situ breast carcinoma in Vaud are still significantly lower than those observed in the United States (between 15 and 17/100000) over the same calendar period. This is attributable to a lower utilisation of mammography, but may also be related to real differences in the incidence of breast lesions in Europe compared to North America.

Entities:  

Mesh:

Year:  1997        PMID: 9291813     DOI: 10.1016/s0959-8049(97)00048-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  11 in total

1.  Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network.

Authors:  Elsebeth Lynge; Antonio Ponti; Ted James; Ondřej Májek; My von Euler-Chelpin; Ahti Anttila; Patricia Fitzpatrick; Alfonso Frigerio; Masaaki Kawai; Astrid Scharpantgen; Mireille Broeders; Solveig Hofvind; Carmen Vidal; Maria Ederra; Dolores Salas; Jean-Luc Bulliard; Mariano Tomatis; Karla Kerlikowske; Stephen Taplin
Journal:  Eur J Cancer       Date:  2013-09-13       Impact factor: 9.162

2.  Reproductive and hormonal risk factors for ductal carcinoma in situ of the breast.

Authors:  Lynette S Phillips; Robert C Millikan; Jane C Schroeder; Jill S Barnholtz-Sloan; Beverly J Levine
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

3.  Overdiagnosis and overtreatment of breast cancer: rates of ductal carcinoma in situ: a US perspective.

Authors:  Anjali S Kumar; Vinona Bhatia; I Craig Henderson
Journal:  Breast Cancer Res       Date:  2005-11-11       Impact factor: 6.466

4.  Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene.

Authors:  N Rahman; J G Stone; G Coleman; B Gusterson; S Seal; A Marossy; S R Lakhani; A Ward; A Nash; A McKinna; R A'Hern; M R Stratton; R S Houlston
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

5.  Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases.

Authors:  Bruno Cutuli; Brigitte De Lafontan; Youlia Kirova; Hugues Auvray; Agnes Tallet; Sandrine Avigdor; Claire Brunaud; Catherine Delva
Journal:  Radiat Oncol       Date:  2015-05-06       Impact factor: 3.481

6.  Comparison of the association of mammographic density and clinical factors with ductal carcinoma in situ versus invasive ductal breast cancer in Korean women.

Authors:  Hyeonyoung Ko; Jinyoung Shin; Jeong Eon Lee; Seok Jin Nam; Tuong Linh Nguyen; John Llewelyn Hopper; Yun-Mi Song
Journal:  BMC Cancer       Date:  2017-12-05       Impact factor: 4.430

7.  Assessment of breast cancer opportunistic screening by clinical-pathological indicators: a population-based study.

Authors:  A Bordoni; N M Probst-Hensch; L Mazzucchelli; A Spitale
Journal:  Br J Cancer       Date:  2009-10-27       Impact factor: 7.640

8.  Pathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breast.

Authors:  Marnix A de Roos; Bert van der Vegt; Jaap de Vries; Jelle Wesseling; Geertruida H de Bock
Journal:  Ann Surg Oncol       Date:  2007-04-24       Impact factor: 5.344

9.  Ductal carcinoma in situ of the breast, a population-based study of epidemiology and pathology.

Authors:  A Kricker; C Goumas; B Armstrong
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640

10.  Risk of subsequent invasive breast carcinoma after in situ breast carcinoma in a population covered by national mammographic screening.

Authors:  R Rawal; J Lorenzo Bermejo; K Hemminki
Journal:  Br J Cancer       Date:  2005-01-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.